Alphatec Holdings, Inc. (NASDAQ:ATEC) Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC grew its holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC) by 28.3% during the 1st quarter, Holdings Channel reports. The firm owned 56,927 shares of the medical technology company’s stock after buying an additional 12,553 shares during the period. SG Americas Securities LLC’s holdings in Alphatec were worth $577,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. GAMMA Investing LLC grew its position in shares of Alphatec by 38,433.3% in the first quarter. GAMMA Investing LLC now owns 2,312 shares of the medical technology company’s stock valued at $228,000 after purchasing an additional 2,306 shares during the last quarter. Comerica Bank boosted its position in Alphatec by 66.8% during the fourth quarter. Comerica Bank now owns 3,116 shares of the medical technology company’s stock worth $29,000 after acquiring an additional 1,248 shares during the last quarter. Quarry LP boosted its position in Alphatec by 79.2% during the fourth quarter. Quarry LP now owns 5,374 shares of the medical technology company’s stock worth $49,000 after acquiring an additional 2,375 shares during the last quarter. Lazard Asset Management LLC acquired a new stake in Alphatec during the fourth quarter worth approximately $76,000. Finally, AlphaQuest LLC acquired a new stake in Alphatec during the fourth quarter worth approximately $80,000. 66.35% of the stock is currently owned by institutional investors and hedge funds.

Alphatec Trading Up 0.5%

Shares of ATEC stock opened at $10.94 on Friday. The company’s fifty day simple moving average is $11.80 and its 200-day simple moving average is $10.85. Alphatec Holdings, Inc. has a 52 week low of $4.88 and a 52 week high of $13.14. The company has a market cap of $1.60 billion, a PE ratio of -9.51 and a beta of 1.10.

Alphatec (NASDAQ:ATEC) last issued its earnings results on Thursday, May 1st. The medical technology company reported ($0.35) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.23). Alphatec had a negative net margin of 25.77% and a negative return on equity of 1,657.19%. The business had revenue of $169.18 million during the quarter, compared to analysts’ expectations of $167.57 million. During the same period in the prior year, the business posted ($0.34) EPS. The business’s revenue was up 22.2% on a year-over-year basis. Equities research analysts expect that Alphatec Holdings, Inc. will post -1.08 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently issued reports on ATEC shares. Wall Street Zen upgraded shares of Alphatec from a “sell” rating to a “hold” rating in a research report on Friday, February 28th. HC Wainwright restated a “buy” rating and set a $20.00 target price on shares of Alphatec in a research report on Monday, April 14th. Lake Street Capital upgraded shares of Alphatec to a “buy” rating and set a $18.00 target price on the stock in a research report on Monday, June 16th. Needham & Company LLC restated a “buy” rating and set a $16.00 target price on shares of Alphatec in a research report on Friday, May 2nd. Finally, Piper Sandler restated an “overweight” rating and set a $15.00 target price (up previously from $13.00) on shares of Alphatec in a research report on Friday, May 2nd. Two equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $17.89.

Insider Activity

In other news, Director Karen K. Mcginnis sold 3,963 shares of the firm’s stock in a transaction dated Wednesday, June 11th. The stock was sold at an average price of $12.11, for a total transaction of $47,991.93. Following the completion of the sale, the director now directly owns 68,709 shares in the company, valued at $832,065.99. This trade represents a 5.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Scott Lish sold 22,727 shares of the firm’s stock in a transaction dated Friday, June 13th. The shares were sold at an average price of $11.07, for a total value of $251,587.89. Following the sale, the chief operating officer now owns 748,918 shares of the company’s stock, valued at $8,290,522.26. This represents a 2.95% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 294,065 shares of company stock valued at $3,633,172. Company insiders own 20.90% of the company’s stock.

Alphatec Company Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.